Comparing Cabozantinib vs Nivolumab
Cabozantinib | Nivolumab |
|
---|
Cabozantinib | Nivolumab |
|
---|---|---|
Prescription only
Prescribed for Renal Cell Carcinoma, Hepatocellular Carcinoma, Neuroendocrine Tumors, Thyroid Cancer. Cabozantinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Head and Neck Cancer, Esophageal Carcinoma, Hepatocellular Carcinoma, Colorectal Cancer, Gastric Cancer, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma -... View more |
|
More about Cabozantinib | More about Nivolumab | |
Ratings & Reviews | ||
Cabozantinib has an average rating of 6.8 out of 10 from a total of 29 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 21% reported a negative effect. |
Nivolumab has an average rating of 5.9 out of 10 from a total of 141 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 40% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Cabozantinib side effects |
View all Nivolumab side effects |
|
Drug Class | ||
Generic Availability | ||
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
N/A |
N/A |
|
Brand Names | ||
Cabometyx, Cometriq | Opdivo | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
99 hours |
640.8 hours |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 534 drugs are known to interact with Cabozantinib:
|
A total of 593 drugs are known to interact with Nivolumab:
|
|
Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | ||
First Approval Date | ||
November 29, 2012 |
December 22, 2014 |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
Professional Resources | ||
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Lenvatinib
Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.